Contractor profile

Sanofi Vaccines US Inc.

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

prime recipient of federal awards · Subsidiary of Sanofi S.A. · France Inferred · UEI NCXBGGQ8YTU9 Source
$765.3M
Obligated
FY2026 · data still posting
5
Funding agencies
99%
From Health and Hum…
4%
Non-competed
9
States
4%
In Pennsylvania
6
Industries

In FY2026, Sanofi Vaccines US Inc. received $765.3M in federal awards from 5 agencies, 99% of it from the Department of Health and Human Services, with 4% of the work performed in Pennsylvania. Across FY2020 to FY2026 its recorded total is $6.5B. FY2026 ended Sep 30 and its data is still posting. Computed

Where this money comes from

Source
FUNDING AGENCIES
SANOFI VACCINES US INC.
HHS
$0.8B
4 other agencies
$0B
Sanofi Vaccines US Inc.
$0.8B
FY2026 obligated
band width = obligations · FY2026 · source: USASpending.gov

Where the work lands

Source
Pennsylvania$29.9M
Oklahoma$2M
District Of Columbia$40.2K
Texas$6.2K
New Jersey$3.3K
Georgia$1.9K
South Carolina$1.7K
West Virginia$560

State breakdown available for 4% of obligations shown

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Sanofi Vaccines US Inc. received $765.3M in federal obligations in FY2026 (data still posting), compared with $1.1B in FY2025.
  • The Department of Health and Human Services accounted for 98% of it.
  • Of its $765.3M in contract obligations, 4% was non-competed, based on FPDS extent-competed codes.
  • Its largest recorded industry was Pharmaceutical Preparation Manufacturing, at $734.4M.

Obligations by year

Computed
$974.8M
FY20
$741.2M
FY21
$707.4M
FY22
$579.6M
FY23
$1.6B
FY24
$1.1B
FY25
$765.3M
FY26 partial
▲ 17%
FY20 to FY25

Awards

Source

Largest active awards by total value

Awards whose period of performance overlaps FY2026, by the amount obligated on each so far.

AwardIDAgencyObligatedStartEndPlace
Maintaining of Embryonated Egg Supply for Non-Seasonal Production of Pandemic Vaccine75A50125C00002Department of Health and Human Services$53.2M2025-02-012027-01-31Pennsylvania

Largest FY2026 awards

Awards that started in FY2026, by the amount obligated on each so far.

No award on record started in FY2026.

What it does (NAICS / PSC)

Pharmaceutical Preparation Manufacturing$734.4M
Biological Product (except Diagnostic) Manufacturing$23.1M
Research and Development in Biotechnology (except Nanobiotechnology)$7.4M
Refrigerated Warehousing and Storage$308.3K
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers$17.5K

Competition

4%non-competed (often called no-bid), of $765.3M in contract obligations in FY2026Computed

This describes how contracts were awarded, not wrongdoing.

Similar federal contractors

Computed
Mckesson Corporation$14.9B
Merck Sharp & Dohme LLC$2.3B
Pfizer Inc$1.1B
Glaxosmithkline, LLC$1.1B
Emergent Biosolutions Canada Inc$118.3M
Exelan Pharmaceuticals Inc$96.2M
Canadian Commercial Corporation$16.4M
Trillamed LLC$1.1M

Corporate family

Single registration: no combined family.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.